Navigation Links
Once-Daily MIRAPEX ER Now Approved by FDA for Both Early and Advanced Parkinson's Disease
Date:3/23/2010

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 138 affiliates in 47 countries and approximately 41,300 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.

In 2008, Boehringer Ingelheim posted net sales of US $17 billion (11.6 billion euro) while spending approximately one-fifth of net sales in its largest business segment, Prescription Medicines, on research and development.

For more information, please visit http://us.boehringer-ingelheim.com.

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.

Back to top

RELATED LINKS

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. ISTA Pharmaceuticals Receives Action Date for FDA Review of Once-Daily XiDay(TM)
2. FDA Approves Once-Daily MIRAPEX ER for the Treatment of Early Parkinsons Disease
3. Tobiras Next-Generation Once-Daily CCR5 Receptor Antagonist Demonstrates Efficacy, Safety and Tolerability in Treatment-Experienced Patients With HIV
4. ISTA Pharmaceuticals Submits Supplemental New Drug Application to the FDA for Once-Daily XiDay(TM)
5. Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide
6. Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C
7. New Data Show Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Demonstrated Significant ADHD Symptom Reduction when Assessed Using the Oppositional Subscale of the Conners ADHD Rating Scale
8. Transave Announces Positive Phase II Results For Once-Daily ARIKACE(TM) in the Treatment of Non-CF Bronchiectasis Patients Who Have Pseudomonas Lung Infections
9. Shire Announces FDA Approval of Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets for the Treatment of ADHD in Children and Adolescents Aged 6 to 17
10. ISTA Pharmaceuticals Announces Positive Preliminary Phase 3 Clinical Results to Support sNDA Filing for Once-Daily Xibrom(TM) 0.09%
11. Analysis of Edoxaban Phase II Data Provides Insight Into Reduced Bleeding Events Seen in Once-Daily Dosing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... , Nov. 21, 2014   Rock Creek ... that the Company is scheduled to present at the ... Francisco, CA on January 12-14, 2015. ... and CEO of Rock Creek Pharmaceuticals, will present preclinical ... cholinergic agonist which exhibits anti-inflammatory pharmacological characteristics. Dr. Mullan ...
(Date:11/21/2014)... Nov. 21, 2014  Abaxis, Inc. (NasdaqGS: ... and consumables for the medical, research, and veterinary markets ... and research markets in the United States ... purchase agreement to acquire 100% of QCR & Trio ... based distribution organization. The transaction closed on November 17, ...
(Date:11/21/2014)... Clementia Pharmaceuticals, Inc.  announced ... has granted Orphan Medicinal Product Designation for ... the treatment of fibrodysplasia ossificans progressiva (FOP). ... disease characterized by painful, recurrent episodes of ... bone formation. This process, known as heterotopic ...
Breaking Medicine Technology:Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 2Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 3Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 4Abaxis Acquires UK-based Distribution Organization 2Abaxis Acquires UK-based Distribution Organization 3Abaxis Acquires UK-based Distribution Organization 4Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 2Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 3
... Aug. 8, 2011 Insmed Incorporated (Nasdaq CM: INSM), a ... six-months ended June 30, 2011. Key Recent ... of data from the open-label phase 2 study of Arikace™ ... (CF) patients with Pseudomonas lung infections ...
... (NYSE Amex: ANX ) today reported financial results ... we head into the second half of the year, we ... into the U.S. market, should it be approved on or ... Brian M. Culley, Chief Executive Officer of ADVENTRX.  "Having a ...
Cached Medicine Technology:Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2011 2Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2011 3Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2011 4Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2011 5Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2011 6Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2011 7Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2011 8ADVENTRX Reports Second Quarter 2011 Financial Results 2ADVENTRX Reports Second Quarter 2011 Financial Results 3ADVENTRX Reports Second Quarter 2011 Financial Results 4ADVENTRX Reports Second Quarter 2011 Financial Results 5ADVENTRX Reports Second Quarter 2011 Financial Results 6ADVENTRX Reports Second Quarter 2011 Financial Results 7
(Date:11/22/2014)... (PRWEB) November 23, 2014 Recently, ... has introduced a new promotion of mag locks for ... provided an attracting discount on these fresh products. Customers ... mag locks for glass doors are in excellent performance. ... browse the website as soon as possible. They ...
(Date:11/22/2014)... Today, Dylan Queen, a renowned brand in wedding dresses, ... business offers a wide range of special occasion dresses, ... them to create multiple looks easily. , According to ... of chic wedding dresses has been prepared for many ... rates now. Dylan Queen can always create what ladies ...
(Date:11/22/2014)... “Due to my knee replacement surgery, I had to use ... the ice grip attachment, I noticed how dangerous the unprotected ... a safer way to prevent possible injuries, so I invented ... offers added safety and stability in slick and icy conditions. ... damage associated with traditional spiked ice grips. As a result, ...
(Date:11/22/2014)... November 22, 2014 In order to provide ... promotion of cocktail party dresses. The business knows that a ... social occasions. , Now, the party dresses supplier’s ... 70% off. As the leading company in fashion industry, LunaDress ... outfit for every customer. So it always raises the professional ...
(Date:11/22/2014)... "My friend went in for a ... machine," said an inventor from Cambria Heights, N.Y. "To ... a second time because the first results were inaccurate. ... the patent-pending MAMO EASY to offer a more comfortable ... the patient from the pain normally involved with this ...
Breaking Medicine News(10 mins):Health News:Discounted Mag Locks for Glass Doors Revealed by Locks-Magnetic.com 2Health News:Dylan Queen Introduces Its New Wedding Dresses 2Health News:LunaDress Unveils Fabulous Cocktail Party Dresses 2
... , , APTOS, Calif., Aug. ... With team practices, after-school activities, homework and more, hectic schedules can leave ... healthy dinner doesn,t always seem like an option. , , ... students of all ages need to be making healthy food choices," said ...
... ... National Cataract Awareness Month this August , ... San Francisco, CA (Vocus) August 11, 2009 -- Did you know that cataracts are ... half the people over age 65 have some degree of cataract development. , , , ...
... , ... Asante Health System looks to the Rhapsody Integration Engine to provide a new and ... that information accessible from the facility,s electronic medical record solution. , ... Santa Monica, Calif. (PRWEB) August 11, ...
... ... Surgery shows that the most popular surgical procedure in the United States is breast augmentation, ... David M. Whiteman, MD says not all women end up being happy with ... , ...
... ... U.S.-based ZyDoc Medical Transcription, a ... announced today that it has completed acquisition of Pennsylvania-based Administrative ... 1994. The acquisition extends a prior strategic business alliance and ...
... 78% Take Medications, Yet Just Over 1 in 4 are ... WASHINGTON, Aug. 11 According to a new study released today by ... 55 and older have had one or more medical condition and 78 ... awareness of the potential impact on driving performance associated with those medications. ...
Cached Medicine News:Health News:Get Back to School the Healthy Way 2Health News:EyeCare America Works to Prevent Blindness Caused by Cataracts 2Health News:EyeCare America Works to Prevent Blindness Caused by Cataracts 3Health News:Community Hospital System Integrates Patient Data with Orion Health 2Health News:Community Hospital System Integrates Patient Data with Orion Health 3Health News:Re-Envision Your Look: Dr. David Whiteman Suggests Breast Revision Surgery as Solution for Women Dissatisfied with Prior Procedures 2Health News:Re-Envision Your Look: Dr. David Whiteman Suggests Breast Revision Surgery as Solution for Women Dissatisfied with Prior Procedures 3Health News:ZyDoc Medical Transcription Completes Acquisition of Administrative Advantage 2Health News:ZyDoc Medical Transcription Completes Acquisition of Administrative Advantage 3Health News:ZyDoc Medical Transcription Completes Acquisition of Administrative Advantage 4Health News:ZyDoc Medical Transcription Completes Acquisition of Administrative Advantage 5Health News:Large Majority of Drivers 55 and Older Unaware of Potentially Dangerous Combination of Medications and Driving, Says New AAA Foundation Study 2Health News:Large Majority of Drivers 55 and Older Unaware of Potentially Dangerous Combination of Medications and Driving, Says New AAA Foundation Study 3
... Available As One Unit, Shaped Like A Fan, ... Of A Phaco Incision. The Gauges Start At ... Up To With 100-Micron Increments. The ... Information As To The Preoperative And Postoperative Incision ...
... Unique Reversible Speculums Designed To ... By Flipping The Speculums Over, Allowing ... Palpebral Fissures To The Widest Possible ... Providing Unobstructed Around-The-Clock Access To The ...
... A Micrometer Handle, Designed To Dial An ... Single Footplate Allows Maximum Visibility, With Titanium ... Blade Tracks Better In Tissue, And Can ... Making A Paracentesis., ,Reusable, Autoclaveable, Made In The ...
2.5V Halogen source, fiber-optic delivery, 2.5X magnification....
Medicine Products: